← Open Payments lookup

NATHAN OLSON: Open Payments

NPI 1528778859 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$619 in 15 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $22 · 2025 $619

Food & beverage: $619
CompanyPaymentsAmount
ABBVIE INC.7$287
AstraZeneca Pharmaceuticals LP2$143
Insulet Corporation1$95
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$44
Novo Nordisk Inc2$35
Lilly USA, LLC1$15

Products named: VRAYLAR, FASENRA, QULIPTA, Omnipod, CAPLYTA, Rybelsus, FARXIGA, MOUNJARO.

Industry payments across NE — which companies pay providers there.